These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

627 related items for PubMed ID: 1569402

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
    Snider DP, Segal DM.
    J Immunol; 1989 Jul 01; 143(1):59-65. PubMed ID: 2471743
    [Abstract] [Full Text] [Related]

  • 11. Functional analysis of the antigen binding region of an MHC class II molecule.
    Rosloniec EF, Beard KS, Freed JH.
    Mol Immunol; 1993 Apr 01; 30(5):491-501. PubMed ID: 7681933
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of peptide antigen presentation by a second peptide.
    de Kroon AI, McConnell HM.
    Proc Natl Acad Sci U S A; 1993 Oct 01; 90(19):8797-801. PubMed ID: 8105466
    [Abstract] [Full Text] [Related]

  • 13. High efficiency of endogenous antigen presentation by MHC class II molecules.
    Calin-Laurens V, Forquet F, Lombard-Platet S, Bertolino P, Chrétien I, Trescol-Biémont MC, Gerlier D, Rabourdin-Combe C.
    Int Immunol; 1992 Oct 01; 4(10):1113-21. PubMed ID: 1336977
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein.
    Zhong G, Reis e Sousa C, Germain RN.
    Proc Natl Acad Sci U S A; 1997 Dec 09; 94(25):13856-61. PubMed ID: 9391117
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Threshold detection of self-antigen/MHC class II complexes formed in vivo: constitutive presentation of an immunodominant epitope of hen egg lysozyme (HEL) in HEL-transgenic mice.
    Kanost D, Basten A, McCluskey J.
    Int Immunol; 1993 Aug 09; 5(8):893-902. PubMed ID: 8398984
    [Abstract] [Full Text] [Related]

  • 19. Processing and reactivity of T cell epitopes containing two cysteine residues from hen egg-white lysozyme (HEL74-90).
    Kang HK, Mikszta JA, Deng H, Sercarz EE, Jensen PE, Kim BS.
    J Immunol; 2000 Feb 15; 164(4):1775-82. PubMed ID: 10657624
    [Abstract] [Full Text] [Related]

  • 20. The mode of protein antigen administration determines preferential presentation of peptide-class II complexes by lymph node dendritic or B cells.
    Guéry JC, Ria F, Galbiati F, Smiroldo S, Adorini L.
    Int Immunol; 1997 Jan 15; 9(1):9-15. PubMed ID: 9043943
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.